In conclusion, the present study confirms the involvement of SLC22A4 in ARSNHL, and highlights the recurrence of the p.C113Y mutation at least in the Northwest African population, where it likely represents a founder NSHL mutation. The gene discussed is SLC22A4; the disease is nodular sclerosis classical Hodgkin lymphoma.